Skip to main content
letter
. 2017 Mar 15;10:69. doi: 10.1186/s13045-017-0439-6

Fig. 1.

Fig. 1

Progression-free survival for patients receiving chidamide monotherapy and patients receiving chidamide combined with chemotherapy